Hypertension in pregnancy

Journal of the American Society of Hypertension

Volumn 4, Issue 2, 2010, Pages 68-78

  Lindheimer, Marshall D ^a   Taler, Sandra J ^b   Cunningham, F Gary ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

blood pressure; eclampsia; obstetrics; Preeclampsia

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CREATININE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LABETALOL; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; NITROPRUSSIDE SODIUM; PHENYTOIN; PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ABDOMINAL PAIN; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CLINICAL EXAMINATION; CONVULSION; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; ECLAMPSIA; FEMALE; HEADACHE; HUMAN; LIFESTYLE MODIFICATION; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MEDICAL RESEARCH; MEDICAL SOCIETY; NEONATAL THROMBOCYTOPENIA; OLIGURIA; POSTMARKETING SURVEILLANCE; PRACTICE GUIDELINE; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TERATOGENICITY; UNITED STATES; URINALYSIS; VISUAL IMPAIRMENT;

EID: 77952100099     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.03.002     Document Type: Article

References (68)

1. Ness R.B., and Roberts J.M. Epidemiology of hypertension. In: Lindheimer M.D., Roberts J.M., and Cunningham F.G. (Eds). Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. (1999), Appleton & Lange, Stamford, Connecticut 43-65 (3rd edition revision in press, May 2009, Elsevier)
2. Villar J., Say L., Gulmezoglu A.M., Marialdi M., Lindheimer M.D., Betran A.P., et al. Pre-eclampsia eclampsia: a health problem for 2000 years. In: Critchly H., MacLean A., Poston L., and Walker J. (Eds). Pre-eclampsia (2003), RCOG Press, London, England 189-207
3. Zandi-Nejad K., Luyckx V.A., and Brenner B.M. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 47 (2006) 502-508
4. Sibai B.M. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 13 (2006) 16-19
5. Zhang J., Villar J., Sun W., Meraldi M., Andel-Aleem H., Mathai M., et al. Blood pressure dynamics during pregnancy and spontaneous preterm labor. Am J Obstet Gynecol 197 (2007) 162e1-e6
6. Harskamp R.E., and Zeeman G.G. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 334 (2007) 291-295
7. Gross C.P., Anderson C.F., and Rowe N.R. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 340 (1999) 1881-1887
8. Davison J.M., and Lindheimer M.D. New developments in preeclampsia. Semin Nephrol 24 (2004) 537-625
9. Moutquin J.M., Garner P.R., Burrows R.F., Rey E., Helewa M.E., Lange I.R., et al. Report of the Canadian Hypertension Society Consensus Conference 2. Non-pharmacologic management and prevention of hypertensive disorders of Pregnancy. CMAJ 157 (1997) 907-919
10. Brown M.A., Hague W.M., Higgins J., Lowe S., McCowan L., Oats J., et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 40 (2000) 133-138
11. Report of the National High Blood Pressure Education Program Working Group on High Blood in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
12. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists (ACOG) 99 (2002) 159-167
13. Cunningham F.G., Leveno K.L., Bloom S.L., Hauth J.C., Gilstrap L.C., and Wenstrom K.D. Williams Obstetrics. 22nd ed. (2005), McGraw-Hill Co, New York, New York 1237
14. Hibbard J.U., Shroff S.G., and Lang R.M. Cardiovascular changes in preeclampsia. Semin Nephrol 24 (2004) 580-587
15. Lindheimer M.D., Conrad K.P., and Karumanchi S.A. Renal physiology and disease in pregnancy. In: Alpern R.J., and Hebert S.C. (Eds). Seldin and Giebisch's The Kidney; Physiology and Pathophysiology. 4th ed. (2008), Academic Press, Elsevier, San Diego, California 2339-2398
16. Friedman E.A., and Neff R.K. Pregnancy, Hypertension: A Systematic Evaluation of Clinical Diagnostic Criteria (1977), PSG Publishing, Littleton, Massachusetts
17. Page E.W., and Christianson R.E. The mean impact of mean arterial pressure in the middle trimester on the outcome of pregnancy. Am J Obstet Gynecol 125 (1976) 740-746
18. Sibai B.M., Caritis S.N., Thon E., Klebanoff M., McNellis D., Rocco L., et al. Prevention of preeclampsia with low-dose aspirin in healthy nulliparous women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 39 (1993) 1213-1218
19. Shennan A.H., and Waugh J. The measurement of blood pressure and proteinuria in pregnancy. In: Critchly H., MacLean A., Poston L., and Walker J. (Eds). Pre-eclampsia (2003), RCOG Press, London, England 305-324
20. August P., and Lindheimer M. Chronic hypertension and pregnancy. In: Lindheimer M.D., Roberts J.M., and Cunningham F.G. (Eds). Chesley's Hypertensive Disorders in Pregnancy, 2nd ed (1999), Appleton & Lange, Stamford, Connecticut 605-633
21. Dugas G., Fuller J., Singh S., and Watson J. Pheochromocytoma and pregnancy: a case report and review of anesthetic management. Can J Anaesth 51 (2004) 134-138
22. Blanco C., Maqueda E., Rubiio J.A., and Rodriquez A. Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. J Endocrinol Invest 29 (2006) 164-167
23. Lindheimer M., Richardson D.A., Ehrlich E.N., and Katz A.I. Potassium homeostasis in pregnancy. J Reprod Med 32 (1987) 517-522
24. Fisher K.A., Luger A., Spargo B.H., and Lindheimer M.D. Hypertension in pregnancy: clinical pathological correlations and remote prognosia. Medicine (Baltimore) 60 (1981) 267-276
25. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 194 (2006) 921
26. Geller D.S., Fahri A., Pinkerton N., Fradley M., Moritz M., Spitzer A., et al. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 (2000) 119-123
27. Menzies J., Magee L.A., MacNab Y.C., Ansermino J.M., Li J., Douglas M.J., et al. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes. Hypertens Pregnancy 26 (2007) 447-462
28. Schiff E., Friedman S.A., Kao L., and Sibai B.M. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 175 (1996) 1313-1316
29. von Dadelszen P., Magee L.A., and Roberts J.M. Subclassification of preeclampsia. Hypertens Pregnancy 22 (2003) 143-148
30. Mattar F., and Sibai B.M. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 182 (2000) 307-312
31. Zeeman G.G., Vollaard E.S., Alexander J.M., McIntire D.D., and Cunningham F.G. "Delta preeclampsia"-a hypertensive encephalopathy in "normotensive" women. Am J Obstet Gynecol 197 (2007) S140
32. Hirshfeld-Cytrin J., Lam C., Karumanchi S.A., and Lindheimer M.D. Late postpartum eclampsia: examples and review. Obstet Gynecol Survey 61 (2006) 471-480
33. Sibai B.M. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103 (2004) 981-991
34. Hladunewich M., Karumanch S.A., and Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2 (2007) 543-549
35. Lindheimer M.D., and Umans J.G. Explaining and predicting preeclampsia (editorial). N Engl J Med 355 (2006) 1056-1058
36. Maynard S., Epstein F.H., and Karumanchi S.A. Preeclampsia and angiogenic imbalance. Ann Rev Med 59 (2007) 61-78
37. Li Z., Zhang Y., Ying Ma J., Kapoun A.M., Shao Q., Kerr I., et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50 (2007) 686-692
38. Dechend R., Homuth V., Wallukat G., Müller D.N., Krause M., Dudenhausen J., et al. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J Soc Gynecol Invest 13 (2006) 79-86
39. Xia Y., Ramin S.M., and Kellems R.E. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50 (2007) 269-275
40. Conrad K.P., and Lindheimer M.D. Renal and cardiovascular alterations. In: Lindheimer M.D., Roberts J.M., and Cunningham F.G. (Eds). Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. (1999), Appleton & Lange, Stamford, Connecticut 263-326 (3rd edition revision in press, May 2009, Elsevier)
41. McMaster M.T., Zhou Y., and Fisher S.J. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 24 (2004) 540-547
42. Sheehan H.L., and Lynch J.P. The pathology of toxemia (1973), Wilkins and Wilkins, Baltimore, Maryland
43. Zeeman G.G., Hatab M.R., and Twickler D.M. Increased cerebral blood flow in preeclampsia with magnetic resonance imaging. Am J Obstet Gynecol 191 (2004) 1425-1429
44. Cipolla M.J. Cerebrovascular function in pregnancy and eclampsia. Hypertension 50 (2007) 14-24
45. Zeeman G.G., Fleckenstein G.L., Twinckler D.M., and Cunningham F.G. Cerebral infarction in preeclampsia. Am J Obstet Gynecol 190 (2004) 714-720
46. Baker P.N., and Cunningham F.G. Platelet and coagulation abnormalities. In: Lindheimer M.D., Roberts J.M., and Cunningham F.G. (Eds). Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. (1999), Appleton & Lange, Stamford, Connecticut 349-375 (3rd edition revision in press, May 2009, Elsevier)
47. Dani R., Mendes G.S., Medeiros Jde L., Péret F.J., and Nunes A. Study of the liver changes occurring in preeclampsia and their possible pathogenetic connection with acute fatty liver of pregnancy. Am J Gastroenterol 91 (1996) 292-294
48. Conde-Agudelo A., Villar J., and Lindheimer M.D. WHO systematic review of screening tests for prediction of preeclampsia. Obstet Gynecol 104 (2004) 1367-1914
49. Widmer M., Villar J., Benigni A., Conde-Agudelo A., Karumanchi S.A., and Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors. Obstet Gynecol 109 (2007) 168-180
50. Villar J., Abalos E., Nardin J.M., Merialdi M., and Carroli G. Strategies to prevent and treat preeclampsia. Evidence from randomized controlled trials. Semin Nephrol 24 (2004) 607-615
51. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A., and PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007) 1765-1766
52. Villar J., Abdel-Aleem H., Merialdi M., Mathai M., Ali M.M., Zavaleta N., et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 194 (2006) 639-649
53. Poston L., Briley A., Seed P., Kelly F., Shennan A., and Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367 (2006) 1145-1154
54. Rumbold A., Crowther C., Haslam R., Dekker G., and Robinson J. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 354 (2006) 1796-1806
55. von Dadelszen P., Menzies J., Gilgoff S., Xie F., Douglas M.J., Sawchuck D., et al. Evidence-based management for preeclampsia. Front Biosci 12 (2007) 2876-2889
56. Sibai B.M., and Barton J.R. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol 196 (2007) 514:e1-9
57. Duley L., Henderson-Smart D.J., Meher S., and King J.F. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2 (2007) CD004659
58. Sibai B.H. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol 190 (2004) 1520-1526
59. Gilbert W.M., Young A.L., and Danielson B. Pregnancy outcome in women with chronic hypertension: a population based study. J Reprod Med 52 (2007) 1046-1051
60. von Dadelszen P., and Magee L.A. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 24 (2002) 941-945
61. Martin Jr. J.N., Thigpen B.D., Moore R.C., Rose C.H., Cushman J., and May W. Stroke and severe preeclampsia, and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol (2005) 246-254
62. Podymow T., August P., and Umans J.G. Antihypertensive therapy in pregnancy. Semin Nephrol 24 (2004) 616-625
63. Abalos E., Duley L., Steyn D.W., and Henderson-Smart D.J. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Review. Cochrane Database Syst Rev 1 (2007) CD002252
64. Magee L.A., Miremadi S., Li J., Ensom M.H., Carleton B., Côtè A.M., et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 193 (2005) 153-163
65. Cooper W.O., Hemandez-Diaz S., Arbogast P.D., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital anomalies after first-trimester exposure to ACE inhibitors. N Engl J Med 354 (2006) 2443-2451
66. Jonsdottir L.S., Arngrimsson R., Geirsson R.T., Sigvaldason H., and Sigfússon N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 74 (1995) 772-776
67. Irgens H.U., Reisaeter L., Irgens L.M., and Lie R.T. Long-term mortality of mothers and fathers after preeclampsia: population-based cohort study. BMJ 323 (2001) 1213-1217
68. Funai E.F., Friedlander Y., Paltiel O., Tiram E., Xue X., Deutsch L., et al. Long-term mortality after preeclampsia. Epidemiology 16 (2005) 206-215